Leerink notes that last night, ASCO published the abstract for the first-in-human trial of BMN-673 in patients with solid tumors. The firm says BMN-673 was well tolerated and showed impressive anti-tumor activity in patients with BRCA mutations. Leerink reiterates an Outperform rating on shares of BioMarin.
Walmart's CEO went from earning $6.50 an hour to $25 million a year—here are his three tips for climbing the corporate ladder like him
"We are not very ambitious. I should be careful about talking about work-life balance, but the Americans just work harder.”
These proven wealth builders could be exactly what you're searching for right now.
In his 2016 letter to Berkshire Hathaway shareholders, legendary investor Warren Buffett wrote, “Every decade or so, dark clouds will fill the economic skies, and they will briefly rain gold. When downpours of that sort occur, it’s imperative that we ...
“We’re definitely not doing what you would think somebody with our income could do with the money,” one six-figure earner said.
Jamie Dimon and Jerome Powell are taking the European viewpoint on soaring debt levels in the U.S.
It's possible to construct a winning long-term investment strategy with just low-cost index funds.
The combination of artificial intelligence (AI) and cybersecurity is a match made in heaven.
The property report includes 85 major metropolitan areas in the U.S. with populations of at least 750,000.
This growth ETF has nicely outperformed the S&P 500 since its inception.
